en
Scientific article
Comment
Open access
English

More evidence for dolutegravir as first-line ART for all

Published inThe Lancet HIV, vol. 7, no. 3, p. e154-e155
Publication date2020
Keywords
  • Africa South of the Sahara
  • Alkynes
  • Benzoxazines
  • Cyclopropanes
  • HIV Infections
  • Heterocyclic Compounds, 3-Ring
  • Humans
  • Oxazines
  • Piperazines
  • Pyridones
  • Risk Assessment
Funding
  • Swiss National Science Foundation - 163878
Citation (ISO format)
ESTILL, Janne Anton Markus, BERTISCH, Barbara. More evidence for dolutegravir as first-line ART for all. In: The Lancet HIV, 2020, vol. 7, n° 3, p. e154–e155. doi: 10.1016/S2352-3018(19)30414-X
Main files (2)
Article (Accepted version)
accessLevelPublic
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal2352-3018
120views
20downloads

Technical informations

Creation04/29/2021 5:35:00 PM
First validation04/29/2021 5:35:00 PM
Update time03/16/2023 12:58:38 AM
Status update03/16/2023 12:58:37 AM
Last indexation01/17/2024 1:48:34 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack